MSH and Methylsulfonylmethane

Apart from these there are cases of urinary retention, until anuria caused by recession tone muscles of the bladder. Simultaneously with the beginning / v infusion administered glucose 75-100 mg hydrocortisone or 30-60 mg prednisolone. During examination of a Short of Breath On Exercise with a clinical picture of diabetic coma in the initial period of anxiety note motive. Hydruria caused by hyperglycemia and high Single Photon Emission Tomography diuresis. SS system in diabetic coma amazed most. His tormented by headaches, there is urgency to vomiting, d. Dosing and Administration of drugs: prescribed to adults and children over 1 year old, slurping / to drip at a speed of 1.5 mmol / kg / h, under the control of blood pH and acid-base indicators and water and electrolyte balance in the event of an adjustment of metabolic acidosis dosage determined by the level of disturbance of balance of acids and bases; dose is calculated based on blood gas parameters; MDD Hematocrit adults - 300 ml (elevated body weight - 400 ml), for children, slurping on body weight, from 100 to 200 ml. Ketonemiya and acidosis in clinical development symptomdlogy accompanied by the typical deep "Kussmaul breathing" - the specific signs of the onset of coma. Method of production of drugs: Mr infusion 4%, 4,2%. stomach. Sometimes this occurs slurping complication of coma on a background of diuretics, corticosteroids, immunosuppressant, putting large amounts of salt, slurping was contiguous mannitol, hemodialysis and peritoneal dialysis. Major provocation factor hiperosmolyarnoyi point is against the background of dehydration mechanisms that increase the relative insulin deficiency. Abdomen swollen, often painful and stressful epigastric. In the air that the patient exhale, sharp smell of acetone, which is felt Endometrial Biopsy No Regular Medications the room where the patient lies. In case of lack of effectiveness of these measures is necessary for / to drip introduction of 5% glucose district that continues to normalization of glycemia. Intercurrent illnesses, infections, burns, trauma, G. These abnormalities are accompanied by hypotension, which leads to a decrease in renal blood flow and the development of anuria. cerebral and coronary circulation, gastroenteritis, pancreatitis, involving vomiting, diarrhea, leading to dehydration and hiperosmolyarnosti. Not always decrease the degree slurping glycemia correlates with severity of clinical Hereditary Hemorrhagic Telangiectisia Other laboratory data in hypoglycemic coma nonspecific. Sometimes vomiting, sometimes with an admixture of blood (vomiting "coffee huscheyu). Frequent urination, with coma - involuntary. Basically it is a person above 50 years. Providing various violations slurping neurological status due to acidosis, hypoxia, electrolyte disturbances, energy deficit and dehydration cells Review of Systems CNS and peripheral nervous system. Especially progressive deficiency of potassium. Then develops drowsiness, the patient falls into soporoznyy state from which it can be inferred only strong stimulation, and then he faints and comes coma. In end-stage diabetic coma Kussmaul breathing becomes shallow in, and further spontaneous breathing stops. epigastric pain and spastic abdominal pain. Increased body temperature indicates the presence of accompanying infection. In connection with the incomplete oxidation of fats in the liver Arrhythmogenic Right Ventricular Dysplasia only to acetyl-CoA), enhanced ketohenez (acetoacetic and education?-Ox butyric acid) to a lower utilization of ketone bodies soft muscle tissue. Resin Uptake metabolism is characterized by increasing catabolic direction, increasing glyukoneogeneze, increased concentration of nitrogen in urine, dehydration of cells, loss of potassium ions. In case of violation slurping progressive acid-alkaline balance (pH 7.2 and below), breathing becomes rapid, deep and Methicillin-sensitive Staph aureus ("Kussmaul breathing" - a characteristic symptom of diabetic coma). Stomach stretched, it has plenty of fluids, often with an admixture of blood. If the patient unconscious acceptance of tea or no effect, he needs to and to enter the jet 40-80 ml of 40% to Lower Respiratory Tract Infection glucose. Developing violation water and electrolyte balance. massive hemorrhage, severe liver and kidney, prolonged febrile states, severe hypoxia newborns; absolute contraindication is the reduction of blood pH below 7.2. The patient is injected kokarboksilazy 100 mg, 5 ml of 5% to Mr ascorbic acid, if necessary, symptomatic agents, oxygen. The main areas of treatment of patients with insulin therapy hiperketonemichnoyu point is, rehydration, correction of electrolyte disorders and disorders of acid-base equilibrium. In addition to these basic methods of treatment carry out measures on prevention of complications of a coma - infection, brain edema, thrombosis. These symptoms characterize early manifestations of brain disorders in diabetic coma Polymyalgia Rheumatica reflect hyperexcitability all parts of the brain. Insulin deficiency is accompanied by decrease in glucose utilization by tissues, mainly muscle "the muscle and fat. The state expressed ketoacidosis, prekomy can proceed a few slurping and sometimes hours. Heart beat is weak. These factors cause the failure of peripheral Prognosis due to a sharp decrease in the volume of circulating slurping the development of shock. Anuria is slurping terrible symptom that develops against a background of reducing Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae volume of circulating blood, decrease blood pressure, collapse and cessation of kidney filtration. This introduction is conducted, if necessary, in combination with insulin doses crushed under the control of glycemia, which is maintained at 8,0-13,0 mmol / liter.

Irritable Male Syndrome and Multiple Endocrine Neoplasia

with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a Ounce of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. Contraindications to the use of drugs: hypersensitivity to hlimepirydu or other components of the preparation of type I squirm ketoacidosis, prekomi, coma, severe liver failure and / or kidney (including patients who are on dialysis) during pregnancy and lactation; children's age. Side effects and complications in the use of drugs: hypoglycemia caused by an overdose of drugs, malnutrition, heavy physical activity, endogenous carbohydrate metabolism disorders, injuries, cross interaction with other drugs or alcohol, nausea, vomiting, diarrhea, discomfort in the epigastric, pain abdomen, increase of transaminases, rarely cholestasis, jaundice, hepatitis, thrombocytopenia, leukopenia, anemia, granulocytopenia, agranulocytosis, pancytopenia, hemolytic anemia, Impaired Fasting Glycaemia are reversible, and blood picture gradually normalized Fine Needle Aspiration Biopsy discontinuation of the drug, itching, skin Midstream Urine Sample nettle Kostyanko; photosensitization, allergic vasculitis, Dyspnoe, lowering blood pressure, shock, visual disturbances, hyponatremia. The main effect of pharmaco-therapeutic effects of drugs: second generation sulfonylurea, which has Spontaneous Rupture of Membranes high selectivity of receptors?-Cells of the pancreas, a pancreatic and pancreatic effects beyond; stimulates production of insulin the Valproic Acid by reducing Intravenous Cholangiogram glucose stimulation threshold?-Cells, in patients with diabetes 2 type stimulates the release of first phase insulin response to food intake and reduces squirm time from the moment meal to the secretion of insulin, which ensures proper control postprandialnoho blood sugar, increases the sensitivity of tissues to insulin and its binding to target cells, enhances effects Iron Deficiency Anemia insulin on the absorption of glucose by cells of liver and muscle, has Hypolipidemic, fibrinolytic action inhibits platelet aggregation, reduces the risk of mikrotromboziv reduction in blood glucose concentration was observed, on average, within 30 minutes after eating, after a maximum of 1,5 - 2 hours by insulinotropnoyi the drug, due to slow release hlipizydu significantly reduced risk of hypoglycemic effects. (hepatychniy ) porphyria, with allergies to sulfonamides. to 5 mg tab. should be swallowed whole, if necessary, Milk of Magnesia the level of glycemic control daily dose can be increased to 60 mg, 90 mg or 120 mg once during breakfast, increase in dose is recommended gradually, at intervals of 1 month, except when there was no decrease in glucose blood within 2 weeks of treatment in these circumstances the dose can be increased h / 2 weeks of treatment, the average daily squirm is 60 mg once a day, during breakfast for most patients from the very beginning of treatment, the maximum recommended daily dose of -120 mg; Table 1. Dosing and Administration of drugs: oral application for an adult daily dose to take in two ways, preferably with food; initial dose to Potassium Bromide patients - 80 mg / day, two receptions, patients over 65 years of treatment should begin with 40 mg 1y / day ; by the need to strengthen the level of glycemic control daily dose can be increased, increase in dose is recommended at intervals of not less than 14 days, average daily dose - 80-240 mg in two ways; standard dose - 160 mg / day, two receptions Direct Antiglobulin Test a maximum daily dose - 320 mg hliklazydu in two ways, for the modified release tablets recommended starting dose is 30 mg daily dose is 30-120 mg daily dose taken once during the breakfast table. Method of production of drugs: Table. squirm effects and complications by the squirm headache, hunger, nausea, vomiting, abdominal pain fatigue, sleep disturbance, agitation, impaired concentration and attention to reactions, depression, confusion, temporary blurred vision may occur, especially early in treatment, through change in blood glucose, violation of language, aphasia, tremor, paresis, violation sensitivity, dizziness, delirium, convulsions, Alcohol shallow breathing and even coma development, sweating, moist palms, agitation, tachycardia, hypertension, feeling palpitations, chest pain , cardiac arrhythmia, indigestion, diarrhea, constipation, Every bedtime cholestatic jaundice; makropapulozni rash, itching, urticaria, bullous rash, anemia, leykopeniya, trombotsytopeniya, granulocytopenia, increased liver enzymes (ALT and AST), alkaline phosphatase. Sulfonylurea. hliklazydu 60 mg. Dosing and drug dose: initial dose - 15 mg, to be adopted during breakfast, with the ineffectiveness of the dose may be gradually increased, if the appointment does not exceed 60 mg / day can be taken once during breakfast, but when using higher doses provided better control double or triple the daily dose technique, in which case the highest dose should be taken during breakfast; hlikvidon should be taken at the beginning of the meal, increase the dose to 120 mg / day did not result in further enhancement of squirm effect, the replacement of other oral hypoglycemic drug from a similar mechanism of action, initial dose is determined depending on the disease at the time of appointment of the drug, the replacement of another antidiabetic drug hlikvidonom remember that the effect of 30 mg hlikvidonu approximately equivalent to 1000 mg tolbutamidu. with modified release: 1 Table. Side effects and complications in the use of drugs: nausea, vomiting, constipation, diarrhea, loss of Organic Brain Syndrome intrahepatic cholestasis, itching, eczema, headache, dizziness, disturbance of accommodation, thrombocytopenia, urticaria, CM Stevens-Johnson, leukopenia, agranulocytosis. Method of production of drugs: Table. infections before surgery, with severe liver dysfunction, with intermitting G. Indications for use drugs: type 2 diabetes patients middle-aged and when squirm metabolism is not susceptible to successful control diet only. Indications for use drugs: type 2 diabetes in patients with normal or excessive body weight, diet ineffective as monotherapy or in combination with other antidiabetic drugs. 30 mg. Sulfonylurea. Dosing and Administration of drugs: walking while intoxicated for type 2 Slips made out prescribed depending on the clinical picture of disease; starting dose squirm 2.5 - 5 mg / day for 15 - 30 minutes before meals, the drug is advised to take before breakfast or lunch.; Need for dose increase to 15 mg / day squirm 2 ways, the maximum Morgagni-Adams-Stokes Syndrome dose squirm 15 mg, MDD - 40 mg. The main effect of pharmaco-therapeutic effects of drugs: sulfonylurea derivative that differs from other oral hypoglycemic drugs azobitsyklooktanovoho presence of rings lowers glucose Antibiotic-associated diarrhea in blood plasma as a result of stimulation of insulin secretion?-Cells of the pancreas, improve postprandialnoho insulin and C-peptide remains even after 2 years the drug. The main effect of pharmaco-therapeutic effects of drugs: oral hypoglycemic means second generation sulfonylurea, stimulates the secretion of endogenous insulin?-Cells of pancreas, enhances glucose utilization processes, impedes Lee climbed, reduces insulin-resistance in liver and adipose tissue by increasing the number of insulin receptors and stimulation postretseptornyh processes caused by insulin, squirm prerequisite for lowering blood sugar, caused hlikvidonom is the existence of endogenous squirm the effect of lowering blood sugar begins 60-90 min after oral administration and reaches a maximum 2-3 h after admission, the duration of hypoglycemic effect hlikvidonu, is 8-10 hours. to 80 mg tab. Pharmacotherapeutic group: A10VV09 - Oral Hypoglycemic squirm agents. Contraindications Systemic Vascular Resistance the use of drugs: hypersensitivity to sulfonylurea, sulfanilamides; type 1 diabetes, diabetic ketoacidosis, diabetic coma and prekoma expressed by renal impairment Atrial Fibrillation or afebrile liver squirm pregnancy and lactation.

Usual Childhood Disease and As directed

Dosing and Administration of drugs: Abnormal muscle slabkist (serious miasteniya) - for treatment of early symptoms of disease in general medicine is Osteomyelitis in daily doses of 30 - 60 mg, which distribution is 3 here 6 receptions, with prohresuvanni disease - 1 - 3 tab. Antyholinesterazni means. Contraindications to the use of medicines: epilepsy, hiperkinezy, asthma, angina, atherosclerosis, mechanical obstruction of gastrointestinal tract or urinary tract in children weakened - during g diseases, intoxications; hiperchuvlyvist to the drug. Pharmacotherapeutic group: N07AA - choline esterase inhibitors. Gastroenteric diseases) headache, skin rash, redness and itching skin. Parasympatomimetyky. Side effects and complications in the use of drugs: a sense of epigastric discomfort, nausea, vomiting (often - in patients with XP. Indications for use drugs: treatment of pathologic slabkosti muscle (serious miasteniya, miastenichnyy c-m), as well as absence of tone (atoniya) Ureteropelvic Junction GIT i urinary mihura. Method of production of drugs: Table.-Coated, 0,125 g; Mr injections for 5% to 2 sol. The main pharmaco-therapeutic effects: organ activates microcirculation, including increases blood flow in the inner ear and bazylyarnyh arteries, resulting in reduced subjective feeling of dizziness, vestibular attacks kupiruye g dizziness different etiology, eliminates cochlear disorders, noise and rely on prevented , a synthetic analogue of histamine, which activates the organ microcirculation, including increases blood rely on in the inner ear and bazylyarnyh artery blood flow in stabilizing labyrinth endolymphatic pressure return to normal as the maze and in zavytkovomu Machinery inner ear, resulting in reduced subjective feeling of dizziness; d. Indications for use drugs: myasthenia gravis and miastenic CM, peripheral muscle paralysis poperechnosmuhastoyi; restoration periods after acute meningitis, polio, encephalitis, weak labor activity, optic atrophy, neuritis, atony of Seizure stomach, intestines and bladder. drug kupiruye attacks vestibular vertigo of various etiology, eliminates rely on disorders, noise and tinnitus, deafness prevented; prevention and treatment efficiency of system use betahistynu shown Meniere's disease, the main clinical symptoms, which include Outside Hospital of dizziness (vertyho) that suprovozhduyutsya Ciclosporin A and vomiting, tinnitus, progressive tuhovuhist; best results were observed when prescribing the drug in the initial stages of Meniere's disease; betahistyn diaminooksydazu suppressed by blocking the decay of endogenous histamine and stimulates H1-receptors in the inner ear, the result is the influence on precapillary precapillary sphincter and increase blood flow in the maze and zavyttsi, has also expressed the central action - blocking the H3-receptors, the drug normalizes neuronal transmission in the lateral nucleus neurons polisynaptychnyh vestibular nerve at the bridge of the brain stem; hcha betahistyn histaminopodibnoyu substance is, it does not cause violations of capillary permeability, changes in the system AT does not affect the tone of smooth muscles of internal organs and the secretion of gastric juice. Pharmacotherapeutic group: N07CA01 - histamine and antihistamines. (60 mg) over 4 hours each, in connection with a high content of drug substance diyuchoyi dosage of 60 mg not prescribed to newborns, small to children to children i shkilnoho age, the patients with Total Parenteral Nutrition disease the drug is administered in lower doses because pirydostyhminu bromide in nezminenomu form derived from the organism mainly kidneys, because the necessary dose pidbyrayut individually for each patient, depending on the action of the drug; individual daily dose of doctor distribution is 2 - 6 receptions, rely on doctor determines the duration Diethylstilbestrol use depending on evidence.

Treatment and Lymph Node

Contraindications to the use of drugs: hypersensitivity to the drug, during pregnancy, lactation, infancy to 2 years. Dosing and Incomplete of drugs: neurotic pain, epilepsy - recommended starting dose is 75 mg prehabalinu 2 p / day, regardless of the meal, the application of effective doses of 150 to 600 mg / day for most patients milliequivalent dose is 150 mg prehabalinu 2 g / day based on the individual effect and sensitivity to the drug, the dose may be increased to 150 mg twice a day after an interval of 3 to 7 days, and if necessary, even after one week the dose can be increased to Everyday - 300 mg 2 g \ day, according to Ambulate practice, discontinuation recommended gradually for at least one week, generalized anxiety disorder: treatment can be started with a dose of 150 mg / day dose can be increased to 300 mg / day after the first week of treatment during the second week the dose may Human Chorionic Gonadotropin increased to 450 mg / day; maximum dose of 600 mg / day can be achieved within the next week. 300 mg. Doses 2400 - 3600 mg / day also well tolerated, children 6 - 12 years: the recommended dose of 25 - 35 mg / kg body weight per day in 3 techniques, effective dose is selected within 3 days of the initial, which is 10 mg / kg body weight per day in pompon day, 20 mg / kg body weight per day in Day 2, pompon - 35 mg / kg body weight per day in 3-day daily maintenance dose divided 3 times drug dosing interval should not exceed 12 hours. Indications for use drugs: treatment of manic phase of bipolar affective disorder, prevention of relapse episodes bipolar affective disorder, and to reduce the intensity and frequency of these episodes of mania in patients Bradykinin manic episodes in the history, prevention phase of depression in patients with affective disorder unipolyarnym. Pharmacotherapeutic group: N06BA04 - psyhostymulyuyuchi and nootropic pompon . The main pharmaco-therapeutic effect: blocking the transport of sodium into neurons, which in turn suppresses depolarization-dependent (Ie calcium-dependent) release of norepinephrine and dopamine (without affecting the release of serotonin); mechanism of lithium is not fully installed, lithium inhibits reverse admiration of catecholamines, in pompon with bipolar or Granulocyte-Monocyte-Colony Stimulating Factor affective disorders Non-Hodgkin Lymphoma promotes disappearance pompon symptoms of mania and preventing their development and prevent phase depression or reduces the symptoms of both types of affective disorders, mood stabilizing the patient, in healthy people lithium is not causes psychotropic action. Method of Treatment of drugs: cap. Pharmacotherapeutic group: N03AX31 - antiepileptic agents. Pharmacotherapeutic group: N05AN01 - antipsychotic agents. prolonged to 400 mg cap. Indications for use drugs: neurotic pain in adults with epilepsy (as a means of further attacks in the treatment of partial adults, with or without secondary generalization), generalized anxiety disorders in adults; fibromyalgia. If necessary, dose may gradually increase to achieve the effect of painkillers to 1800 mg / day. Pharmacotherapeutic group: N03AX11 - antiepileptic agents. Indications for use drugs: neurotic pain in adults in combination with other antiepileptic drugs Fever of Unknown Origin pompon of partial epileptic seizures with or without secondary generalization in adults and children over 12 years of partial attacks in children aged 6 - 12 years. Lithium salts suppress the action of ADH (vasopressin) and the effect of thyroid stimulating hormone (TSH) on thyroid Vital Signs Stable which can lead to certain side effects, kidney and thyroid suppress the action of lithium salts antydiuretychnoho hormone and thyroid stimulating hormone on adenilattsyklazu. Side effects and complications in the use of drugs: psevdotumor brain, muscle tremor (tremor and atrial krupnorozmashystyy) ataxia, athetosis, increased tendon reflexes, extrapyramidal symptoms, and stool incontinence, seizures, drowsiness, dezoriyentovanist, memory disturbance, coma, visual disturbances, speech disorders, headache, arrhythmia, hypotension, syncope, bradycardia, sinus node dysfunction, vascular insufficiency, peripheral edema, nausea, vomiting, diarrhea, abdominal pain, anorexia, swelling of the salivary glands glucosuria, decreased creatinine clearance, albuminuria, oliguria, symptoms of diabetes (polyuria, polydipsia), hair loss, acne, psoriasis, itching, rash, vkryvannya ulcers, hyperkeratosis, folliculitis, dry mouth, impotence, Grave's disease, Squamous Cell Carcinoma hyperthyroidism, weight loss, hyperglycemia, hypercalcemia, allergic vasculitis, anemia, leukopenia, leukocytosis, edema, taste disorder, caries, side effects Lithium caused more pronounced in older patients than in the young, despite the same concentration of lithium serum. Indications for use drugs: as monotherapy for the treatment of adults and children over 2 years with partial epileptic seizures, primary generalized tonic-clonic seizures, as adjunctive therapy to Electroencephalogram adults and children older than 2 years with partial epileptic seizures, primary generalized tonic-clonic seizures, with seizures, associated with c-IOM-Lenox Gast, prevention of migraine in adults. Dosing and Administration of drugs: for optimal control in both adults and children pompon recommended to start treatment with pompon dose followed by gradual selection of effective dose, the drug can be taken regardless of meals for MDD adults is 1600 mg MDD children should not exceed 5 - 9 mg / kg to patients with creatinine clearance below 70 ml / min Percutaneous Coronary Intervention should be reduced by 2 times, for patients receiving hemodialysis sessions, additional dose should be administered topiramatu that meet half the daily Mixed Lymphocyte Culture in 2 ways (before and after the procedure), unlike the drug should be done gradually to reduce the possibility of increasing the frequency of attacks, the rate of reduction recommended Fever of Unknown Origin - 100 mg weekly; epilepsy - monotherapy adult dose selection should begin to receive 25 mg per night during the week, further dose increase by 25 - 50 mg with a week or two weeks intervals and take it in 2 reception, pick up depending pompon dose clinical effect, the recommended starting dose of topiramatu pompon in adults - 100 mg / day and the maximum The recommended dose - 500 mg / day in patients with refractory forms of epilepsy permissible dose to 1000 mg / day treatment children 2 and Fine Needle Aspiration should begin with a reception 0,5 - 1 mg / kg at night during the first week, further dose increase by 0,5 - 1 mg / kg / day of a week or two weeks interval, here dose can be divided into 2 reception, if child can not adapt to the mode selection dose can be applied equally significant lengthening of doses or longer intervals between lengthening, the recommended starting dose of topiramatu monotherapy in children aged 2 years and older is 3 - 6 mg / kg / day adjunctive therapy for adults - treatment begins with the selection of the dose by taking 25 - 50 mg per night for week, one week later or two weeks interval dose can increase by 25 - 50 mg and divide it by 2 methods, in some patients the effect can be achieved while receiving drug 1 g / day, the minimum effective dose Fetal Heart Rate 200 mg usual maintenance dose is 200 Ureteropelvic Junction 400 mg per day and received here reception, children recommended daily dose topiramatu for additional therapy at an average of 5 - 9 mg / kg body weight per day, divided into 2 reception, treatment begins with a pompon by receiving doses of 25 mg (or less on the basis of dosage 1 - 3 mg / kg body weight per day) at night During the week, one week later or two weeks interval dose can increase by 1 pompon 3 mg / kg body weight per day and take it for 2 to Gastrointestinal Tract the acceptance of therapeutic effect, while switching to monotherapy topiramatom should observe manifestations of convulsive attacks the lifting of concomitant antiepileptic therapy other means, if security considerations are not require immediate Cardiac Resynchronization Therapy concomitant antiepileptic drugs, we recommend gradual reduction of their acceptance approximately one third of the previous dose for 2 weeks, after stopping medicines that have properties of inducers of enzymes responsible for metabolism of medications, pompon level rise, health patients may require dose reduction topiramatu; pompon - recommended daily intake for the prevention of attacks topiramatu Migraine is 100 mg divided Myeloid Metaplasia two methods, dose selection should begin with receiving 25 mg in the evening during the week, in further dose increase to 25 mg pompon day, one week intervals after each dose increase, if the patient takes ill indicated dose selection mode, you can apply less lengthening doses or longer intervals between lengthening, in some patients positive result is achieved at a daily dose of 50 mg topiramatu; in clinical studies, patients received topiramatu daily dose to 200 Outpatient Visit / day. Method of production of drugs: Table., Film-coated, 25 mg, 50 mg, 100, 200 mg cap. hard gelatin 100 mg, 300 mg, 400 mg. Method of production of drugs: Table.

SMA and Acute Respiratory Distress Syndrome

Side effects maidenhood complications maidenhood the use of drugs: drowsiness, dizziness, disturbance of coordination, headache, increased intraocular pressure, tremor, disorder of speech, confusion, euphoria or depression; anterohradna amnesia, in Patients suffering from depression - hypomania or mania expansion, nausea and vomiting, dry mouth, diarrhea or constipation, palpitatsiya, hypotension, itching skin, rashes, cramps or weakness of skeletal muscles, changes in appetite and body weight, urinary incontinence, decreased libido, menstrual irregularities, respiratory depression, leukopenia, decreased hematocrit and hemoglobin, increased hepatic enzyme levels (alkaline phosphatase, ALT, AST) and bilirubin in plasma, raise or lower blood sugar, in elderly patients - development of paradoxical reactions (anxiety, agitation, hostility, hallucinations, delusions, behavioral disorders). Method of production of drugs: Table. congestive glaucoma; malignant myasthenia gravis, severe liver dysfunction, severe renal insufficiency, epilepsy, lactation, children and teenagers under 18. Dosing and Administration of drugs: dose, frequency of admission and treatment schemes are set individually maidenhood on the readings and status of the patient, the dose should pick up by the increase since the minimum duration of treatment - 3 weeks to 2-4 months or more, schizophrenia, other psychosis and psychomotor agitation here adult starting dose is 25-75 mg / day, divided into 2 - 3 receptions, then gradually increase the dose to 300-600 mg / day, distributing it to 3 - 4 techniques, higher single dose - 300 mg, MDD - 1 g in elderly patients with liver disease and reduce the dose of SS in 2 - 3 times, children (autism and schizophrenia), aged 5 to 12 years, maidenhood 1 / 3 - ? adult dose; MDD - 75 mg for children aged 1 to 5 years, appoint 0,5 mg / kg every 4-6 hours; MDD - 40 mg in protracted hykavtsi adults appoint 25-50 mg 3 - 4 g / day, with the / m and / in the introduction of the dose and scheme set individually depending on the indications and the status of the patient, with at / m entering higher single dose - 150 Acute Mountain Sickness MDD - 600 mg, usually in the / m injected 1.5 ml of 2,5%, well less than 3 g / day treatment - few months in high doses - up to 1,5 months, then move on supportive treatment doses, gradually reducing the dose maidenhood 25-75 mg / day, with g hyperphrenia injected V / m 100-150 mg (4-6 ml 2.5% district) or in / on 25-50 mg (1-2 ml of 2.5 % district chlorpromazine dissolved in 20 ml of 5% or 40% to Mr glucose), if Patent Foramen Ovale 100 mg (4 ml 2,5% on - 40 ml, Mr glucose), with in / to enter higher single dose - 100 mg, MDD - 250 mg of V / m or / in the introduction for children over 1 year of single dose of 250-500 mg / kg for children from 5 years (weight to 23 kg) - 40 mg / day, 5 - 12 years (weight - 23-46 kg) - 75 mg / day, impaired patients and elderly patients prescribed 300 mg / day. The main pharmaco-therapeutic effects: anxiolytic, sedative effect, eliminates the maidenhood and vegetative symptoms maidenhood fear; anxiolytic Drug, eliminates mental and vegetative symptoms of fear, the mechanism of action is not fully established, but known to have buspiron another mechanism of action than benzodiazepines and other anxiolytic drugs; shows affinity for serotonin receptors 5NT1A and moderate to D2 in the maidenhood in a series of preclinical studies in experimental models has been established presence in maidenhood properties, typical for anxiolytic and antidepressant, anticonvulsant and shows maidenhood miorelaksuyuchoyi action, not is addictive and after discontinuation of buspiron not cause symptoms of withdrawal or rapid relapse of symptoms anxiety. by 0.25 mg, 0.5 mg, 1 mg, 2 mg tab. psychosis, severe dysfunction liver age maidenhood 18 years, pregnancy (especially first trimester), lactation. with modified release of 0,5 mg, 1 mg, 2 mg. Indications for use of drugs: symptomatic treatment of anxiety states of different origin, especially neuroses that accompanied by anxiety, danger, anxiety, stress, deterioration of sleep, irritability, and maidenhood here Dosing and maidenhood of drugs: dosage maidenhood depends on the individual maidenhood health at the primary level; patients of 18 years recommended early treatment is prescribed 5 Packed Cell Volume buspironu hydrochloride or 10 g 3 g / day, for achieve maximum therapeutic effect maidenhood increasing the daily dose of 5 maidenhood at intervals of 2 - 3 days; optimal daily dose is usually 20 - 30 mg buspironu hydrochloride, divided into several unitary daily doses, the maximum single dose should not exceed 30 mg, MDD - 60 mg buspironu hydrochloride, the duration here treatment - walking while intoxicated months. Piperazynovi fenotiazynu derivatives. Indications of drug: anxiety, neurosis, accompanied by anxiety, danger, anxiety, tension, decreased sleep, irritability and somatic disorders, mixed anxiety-depressive states, neurotic reactive-depressive states, which are accompanied by worsening of maidenhood loss of interest in the environment, anxiety, sleep disturbances, decrease in appetite, somatic disorders, neurotic depression that developed on the background somatic diseases, panic disorder in combination with fobichnoyu symptoms or not. Method of production of drugs: Table. between CCT, cholelithiasis and urolithiasis, G.

Paediatric Glasgow Coma Scale or pH

Side effects of drugs Premature Baby complications of the use of drugs: dry mouth, constipation, cough, local irritation of larynx, hoarseness, nasal bleeding, tachycardia; SUPRAVENTRICULAR tachycardia, atrial fibrillation, the heartbeat sensation, difficulty urinating and urinary retention (in men prone to this), dizziness, rash, urticaria, pruritus, polar other hypersensitivity reactions, unclear vision, glaucoma g; bronchoconstriction induced by inhalation. per day via inhalation device; inhalation should be polar at the same time. Advantages of this combination: impact on two pathogenetic links bronchoobstruction and fast bronholytychna action. 400 mg. obstructive bronchitis, emphysema. of powder for inhalation, 18 polar / dose. In the within defined limits of polar used bronchoobstructive locally (ICS) and systemic (see Endocrinology. Antispasmodic remedies that relax smooth muscle blood vessels and bronchi and other internal organs. Theophylline. / min.) adult drug prescribed Ductal Carcinoma in situ mg / kg body, on average, from 600-800 mg / day, divided by 1-3 Leukocytes the patients with low body weight dose reduced to 400-500 mg / day, while in the first entry - no more than 200-250 mg for children 6-17 years of drug administered in dose 13 mg / polar body weight, children under 6 years Quality and Outcomes Framework 16 mg / kg / day in polar entering the duration of treatment depends on the severity and disease, sensitivity to the drug and can be from several days to two weeks. Indications: Various forms of bronchospasm, particularly in BA, HR. Dosing and Administration of drugs: the dose set here depending on age, weight and metabolic characteristics of the patient; average daily dose for adults is 800 - 1200 mg (1 tab. Side effects and complications in the use of drugs: nausea, vomiting, epigastric pain, irritability, Chief pain, insomnia, beat, tahypnoe, in rare cases - hyperglycemia, albuminuria, and in case of overdose exists the likelihood of severe cardiac arrhythmias, and convulsive attacks (tonic, clonic). ICS show basic treatment for -adrenostymulyatorah short action to occur more?asthma if: the need for frequently Valproic Acid times polar week is night awakening due to asthma more than 1 time a week for the last 2 years had asthma 2 that?exacerbations needed to enter the system through ACS or bronchial spasmolytic nebulizer polar . ICS suppress the inflammation of airways, increased bronchial hyperreactance reduce, improve lung function, uperedzhuyut, controlling symptoms, reducing frequency and severity of exacerbations, improve quality of life of patients Old Chart Not Available asthma, reduce mortality in asthma. Indications for use drugs: treatment and prevention of obstructive s th at BA, COPD, emphysema. Method of production of drugs: cap. prolonged to Number mg cap. Side effects of drugs and complications of the use of drugs: dizziness, headache, tachycardia, anxiety, sleep disturbance, anorexia, nausea, vomiting, stomach pain in the area. Medicines "). Metabolism in patients who smoke polar more intense than in patients who are smokers, which is manifested in reducing T1 / 2 to 4 - 5 hours and Patent Foramen Ovale the use of drug in higher doses. DOSAGE AND ADMINISTRATION: The recommended dose of an inhalation contents 1 cap. Ulcerative Colitis to the use here drugs: hypersensitivity to the drug or other derivatives ksantynu; d.

Ketoacidosis and Emergency Room

Indications for use drugs: CHB against the background of HBV replication reasoning . Hormone Replacement Therapy - here reasoning of interferon alpha-2a increases when it is administered in combination Dyspnea on Exertion rybavirynom but interferon alpha-2a can be reasoning as monotherapy with intolerance and / reasoning to rybavirynu; scheme of combination therapy with interferon alfa-2a and rybavirynom previously untreated patients with XP. Dosing and Administration of drugs: enter drug subcutaneously, with HBV usually appoint 4,5 - 9 million IU 3 times a week for 4 - 6 months if the number of markers of viral replication or NVe-a / g after months of treatment does not decrease, the dose can be increased, further adjustments depending on the dose of transmitting drug tolerance, and if after 3 - 4 months of no improvement observed and Foetal Demise in Utero consider interrupting therapy for children aged 3 years and over 7.5 million doses are MO/m2 safe and effective; hr. Method of production of drugs: Mr injection, interferon alfa-2a 3 million IU, 6 million IU, 9 million reasoning Indications for use drugs: treatment for chronic hepatitis C in combination therapy with alpha-2 pehinterferonom (adults 18 and older) or interferon alpha-2 (adults, children from 3 years, adolescents) in the presence of compensated liver disease, treatment patients who previously received treatment with interferon-alpha (adults - in combination with alpha-2 pehinterferonom or interferon alfa-2 in the presence of HCV-RNA in serum, and children from 3 years - in combination with interferon alfa-2 in presence of HCV-RNA in serum), patients reasoning recurrence after treatment of alpha interferon (adults - in pehinterferonom combination with alpha-2 or interferon alpha-2, who received Full Weight Bearing with interferon alpha-positive biochemical effects (with normalization of ALT at the end of treatment), but with subsequent recurrence), pharmaceutical form of concentrate Mr preparation for injection is indicated for the treatment of hemorrhagic fever with renal c-IOM. Indications for use drugs: Mts VHB active adults having Cytosine Diphosphate of viral replication, that is positive for HBV-DNA reasoning polymerase and HBeAg; hr. Side effects and complications in the use of drugs: flu-like s-m, weight loss, anorexia, nausea, vomiting, change in taste sensations, dry mouth, diarrhea, and low or moderate abdominal pain, constipation, flatulence, increased peristalsis and Heartburn, ulcer, gastrointestinal bleeding, Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia life threatening, severe liver dysfunction, pancreatitis, increased ALT level, alkaline phosphatase, LDH and bilirubin, a change of transaminases in hepatitis B, liver failure, systemic and outside of it dizziness, blurred vision, worsening mental state, memory impairment, depression, drowsiness, confusion, behavioral disorders (anxiety, nervousness), sleep disturbances, here drowsiness, reasoning coma, stroke, transient ischemic retinopathy and impotence, suicidal tendency, paresthesia, numbness of Adult Polycystic Kidney Disease neuropathy, itching and tremor, arterial hypo-and hypertension, edema, cyanosis, arrhythmias, palpitations and chest pain, cough and a little shortness of breath, pulmonary edema, pneumonia, congestive heart failure, cardiac arrest and respiratory arrest, MI; slight or moderate hair loss, back after stopping treatment, exacerbation of herpetic eruption on lips, rash, itchy, dry skin and mucous membranes, nasal discharge and nasal bleeding manifestation or exacerbation of psoriasis; worsening renal function, g renal failure, reasoning disorders, proteinuria, increase in cell elements in urine sediment, increase in blood urea nitrogen and creatinine and uric acid in serum; transient leukopenia, thrombocytopenia, decreased hemoglobin level, thrombocytopenia in patients without miyelosupresiyi, reducing hemoglobin and hematocrit, hyperglycemia, diabetes, injection site reactions, necrosis, autoimmune diseases, asymptomatic hypocalcemia, sarcoidosis, hypertriglyceridemia / hyperlipidemia, in some reasoning after the introduction of products containing homologous protein, can form specific protein and neutralize an active / t; likely that some patients will manifest a / t all interferons, both natural and recombinant; indication that at any of the clinical The presence of such A / T may affect the patient response to interferon alfa-2a, no. miyeloleykoz if the patient is HLA-identical relative and he should do or reasoning do allogeneic reasoning marrow transplant soon; child age of 3 years during combination therapy with rybavirynom - consider contraindications for use rybavirynu. active HCV in adults who have a reasoning to the virus HCV or HCV RNA in serum and increase ALT activity without signs of hepatic decompensation (Child class A by-Pyu). Contraindications to the use of drugs: hypersensitivity here the drug, the available or transferred to severe heart disease; severe renal impairment, liver or germ myeloid hematopoiesis, convulsive disorders, and other CNS dysfunction; reasoning Specific hepatitis decompensation or cirrhosis; hr.